Globalny koszt społeczno-gospodarczy padaczki pierwotnej: szacunki na 2021 rok i prognozy do 2050 roku
PubMed➕ 21.11.2026Neuroepidemiology
The global macroeconomic burden of idiopathic epilepsy: estimates for 2021 and projections to 2050
W skrócie
Badanie pokazuje, że padaczka pierwotna powoduje na świecie ogromne straty finansowe i zdrowotne - w 2021 roku szacowano je na ponad bilion dolarów, czyli około 0,7% światowego produktu krajowego brutto. Prognozuje się, że do 2050 roku strata ta wzrośnie do 1,3 biliona dolarów, zwłaszcza w biedniejszych krajach i Afryce Subsaharyjskiej, gdzie choroba bardziej dotyka ludzi pracujących i zarabiających. Autorzy podkreślają, że potrzeba większych inwestycji w profilaktykę, dostęp do leków i edukację społeczną, szczególnie w krajach o niskich dochodach.
Oryginalny abstract (angielski)
BACKGROUND: Idiopathic epilepsy imposes substantial health and economic burdens worldwide, yet evidence on welfare-based macroeconomic losses attributable specifically to idiopathic epilepsy remains limited. This study estimated the global, regional, and national welfare burden of idiopathic epilepsy across 190 countries and territories in 2021 and projected this burden to 2050. METHODS: Disability-adjusted life years (DALYs) and healthy life expectancy were obtained from the Global Burden of Disease Study 2021; gross domestic product (GDP) and GDP per capita from the World Bank's World Development Indicators database; and country-, sex-, and age-specific population estimates and medium-variant projections from the United Nations World Population Prospects 2024. VLW was estimated using the value of a statistical life and the value of a statistical life year and expressed in purchasing power parity-adjusted constant 2021 international dollars. Age- and sex-specific DALY rates were projected to 2050 using exponential smoothing state-space models and combined with the corresponding population projections. RESULTS: In 2021, the global undiscounted VLW attributable to idiopathic epilepsy was Int$1,138.013 billion, equivalent to 0.737% of global GDP. By 2050, it was projected to reach Int$1,287.730 billion, equivalent to 0.834% of the 2021 global GDP benchmark and 13.156% above the 2021 level. Absolute VLW was concentrated in high-income and populous regions, particularly the United States, China, and India, whereas the relative burden was greatest in low-SDI regions and Sub-Saharan Africa. Higher VLW was observed among adolescents, young and middle-aged adults, and males. CONCLUSIONS: Idiopathic epilepsy causes substantial and growing global welfare losses with marked inequalities. Strengthening prevention, diagnosis, affordable antiseizure medication access, primary care integration, and anti-stigma interventions is essential, especially in low-resource settings.
Metadane publikacji
Journal
Neuroepidemiology
Data publikacji
20.11.2026
PMID
43062887
DOI
10.1159/ned/adwag064
Autorzy
Jin X, Sun Y, Wang Y, Li R, Li H, Yu H, Wang Y, Huang W